Bruker's Q1 Revenues Up 29 Percent

The company's Bruker Scientific Instruments Segment, which contains its mass spectrometry products, saw revenues climb to $335.8 million, a 29 percent rise from $260.3 million a year ago.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.